Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Fluids in the management of sepsis in children: a review of guidelines in the aftermath of the FEAST trial.

Dewez JE, Nijman RG, Yeung S.

Arch Dis Child. 2019 Dec;104(12):1236. doi: 10.1136/archdischild-2019-317595. Epub 2019 Jul 20. No abstract available.

2.

Biomarkers for Infection in Children: Current Clinical Practice and Future Perspectives.

Stol K, Nijman RG, van Herk W, van Rossum AMC.

Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S7-S13. doi: 10.1097/INF.0000000000002318.

PMID:
31205237
3.

Effects of saline or albumin fluid bolus in resuscitation: evidence from re-analysis of the FEAST trial.

Levin M, Cunnington AJ, Wilson C, Nadel S, Lang HJ, Ninis N, McCulloch M, Argent A, Buys H, Moxon CA, Best A, Nijman RG, Hoggart CJ.

Lancet Respir Med. 2019 Jul;7(7):581-593. doi: 10.1016/S2213-2600(19)30114-6. Epub 2019 Jun 10.

4.

Identification and treatment of paediatric sepsis: getting the balance right.

Carter MJ, Stilwell PA, Nijman RG, Eisen S.

Arch Dis Child. 2018 Dec;103(12):1185-1186. doi: 10.1136/archdischild-2018-314865. Epub 2018 May 25. No abstract available.

PMID:
29802138
5.

Clinical prediction models for young febrile infants at the emergency department: an international validation study.

Vos-Kerkhof E, Gomez B, Milcent K, Steyerberg EW, Nijman RG, Smit FJ, Mintegi S, Moll HA, Gajdos V, Oostenbrink R.

Arch Dis Child. 2018 Nov;103(11):1033-1041. doi: 10.1136/archdischild-2017-314011. Epub 2018 May 24.

PMID:
29794106
6.

Validation of the Feverkidstool and procalcitonin for detecting serious bacterial infections in febrile children.

Nijman RG, Vergouwe Y, Moll HA, Smit FJ, Weerkamp F, Steyerberg EW, van der Lei J, de Rijke YB, Oostenbrink R.

Pediatr Res. 2018 Feb;83(2):466-476. doi: 10.1038/pr.2017.216. Epub 2017 Nov 8.

PMID:
29116239
7.

Comparison of peripheral and central capillary refill time in febrile children presenting to a paediatric emergency department and its utility in identifying children with serious bacterial infection.

de Vos-Kerkhof E, Krecinic T, Vergouwe Y, Moll HA, Nijman RG, Oostenbrink R.

Arch Dis Child. 2017 Jan;102(1):17-21. doi: 10.1136/archdischild-2015-308519. Epub 2016 Jun 23.

PMID:
27339165
8.

Neutrophil CD64 expression is not a useful biomarker for detecting serious bacterial infections in febrile children at the emergency department.

van Veen M, Nijman RG, Zijlstra M, Dik WA, de Rijke YB, Moll HA, Neele M, Smit FJ, Oostenbrink R.

Infect Dis (Lond). 2016;48(5):331-7. doi: 10.3109/23744235.2015.1118156. Epub 2015 Dec 16.

PMID:
26674927
9.

[Impact of a clinical decision model for febrile children at risk for serious bacterial infections at the emergency department: a randomized controlled trial].

de Vos-Kerkhof E, Nijman RG, Vergouwe Y, Polinder S, Steyerberg EW, van der Lei J, Moll H, Oostenbrink R.

Ned Tijdschr Geneeskd. 2015;159:A9552. Dutch.

PMID:
26507069
10.

C-Reactive Protein Bedside Testing in Febrile Children Lowers Length of Stay at the Emergency Department.

Nijman RG, Moll HA, Vergouwe Y, de Rijke YB, Oostenbrink R.

Pediatr Emerg Care. 2015 Sep;31(9):633-9. doi: 10.1097/PEC.0000000000000466.

PMID:
26181498
11.

Impact of a clinical decision model for febrile children at risk for serious bacterial infections at the emergency department: a randomized controlled trial.

de Vos-Kerkhof E, Nijman RG, Vergouwe Y, Polinder S, Steyerberg EW, van der Lei J, Moll HA, Oostenbrink R.

PLoS One. 2015 May 29;10(5):e0127620. doi: 10.1371/journal.pone.0127620. eCollection 2015.

12.

C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study.

Nijman RG, Moll HA, Smit FJ, Gervaix A, Weerkamp F, Vergouwe Y, de Rijke YB, Oostenbrink R.

Pediatr Infect Dis J. 2014 Nov;33(11):e273-9. doi: 10.1097/INF.0000000000000466.

PMID:
25093971
13.

[Guideline for febrile children in the hospital setting; relevance for general practitioners and paediatricians].

Nijman RG, Oteman N, Oostenbrink R.

Ned Tijdschr Geneeskd. 2014;158:A7331. Review. Dutch.

PMID:
25027213
14.

Use of alarm features in referral of febrile children to the emergency department: an observational study.

van Ierland Y, Elshout G, Moll HA, Nijman RG, Vergouwe Y, van der Lei J, Berger MY, Oostenbrink R.

Br J Gen Pract. 2014 Jan;64(618):e1-9. doi: 10.3399/bjgp14X676393.

15.

Clinical prediction model to aid emergency doctors managing febrile children at risk of serious bacterial infections: diagnostic study.

Nijman RG, Vergouwe Y, Thompson M, van Veen M, van Meurs AH, van der Lei J, Steyerberg EW, Moll HA, Oostenbrink R.

BMJ. 2013 Apr 2;346:f1706. doi: 10.1136/bmj.f1706.

16.

Vital signs should be maintained as continuous variables when predicting bacterial infections in febrile children.

Spruijt B, Vergouwe Y, Nijman RG, Thompson M, Oostenbrink R.

J Clin Epidemiol. 2013 Apr;66(4):453-7. doi: 10.1016/j.jclinepi.2012.09.014. Epub 2013 Jan 8.

17.
18.

Can urgency classification of the Manchester triage system predict serious bacterial infections in febrile children?

Nijman RG, Zwinkels RL, van Veen M, Steyerberg EW, van der Lei J, Moll HA, Oostenbrink R.

Arch Dis Child. 2011 Aug;96(8):715-22. doi: 10.1136/adc.2010.207845. Epub 2011 Apr 20.

PMID:
21508058
19.

Parental fever attitude and management: influence of parental ethnicity and child's age.

Nijman RG, Oostenbrink R, Dons EM, Bouwhuis CB, Moll HA.

Pediatr Emerg Care. 2010 May;26(5):339-42. doi: 10.1097/PEC.0b013e3181db1dce.

PMID:
20404784
20.

Silent uterine rupture, an unusual cause of anhydramnios.

Teunissen KK, Lopriore E, Nijman RG, Brouwer PA, van Kamp IL.

Am J Obstet Gynecol. 2007 Feb;196(2):e8-9.

PMID:
17306642
21.

Persistent retained placenta percreta: methotrexate treatment and Doppler flow characteristics.

Nijman RG, Mantingh A, Aarnoudse JG.

BJOG. 2002 May;109(5):587-8. No abstract available.

Supplemental Content

Loading ...
Support Center